Pages that link to "Q35576402"

The following pages link to Coronary restenosis: a review of mechanisms and management (Q35576402):

Displaying 39 items.

• Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention (Q24187868) (← links)
• Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention (Q24202716) (← links)
• Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunction (Q26824460) (← links)
• MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation (Q30418359) (← links)
• Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. (Q34606581) (← links)
• Stent-induced coronary artery stenosis characterized by multimodal nonlinear optical microscopy (Q34661482) (← links)
• A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention (Q35532916) (← links)
• The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). (Q35621438) (← links)
• Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease (Q38635466) (← links)
• Biocompatibility screening in cardiovascular implants (Q36154330) (← links)
• The impact of insulin resistance on endothelial function, progenitor cells and repair (Q36892494) (← links)
• Nitinol-based nanotubular coatings for the modulation of human vascular cell function (Q37095166) (← links)
• Avoiding restenosis: is there a role for glucocorticoids in the drug-eluting stent era? (Q37362731) (← links)
• Use of Micropatterned Thin Film Nitinol in Carotid Stents to Augment Embolic Protection (Q37542218) (← links)
• Factors that affect mass transport from drug eluting stents into the artery wall. (Q37705587) (← links)
• Computational structural modelling of coronary stent deployment: a review (Q37768719) (← links)
• Percutaneous coronary intervention for small-vessel coronary disease: highlight on the everolimus-eluting stent (Q37786640) (← links)
• Do statins have a role in reduction/prevention of post-PCI restenosis? (Q37941867) (← links)
• Impact of metabolic syndrome on re-stenosis development: Role of drug-eluting stents (Q37973296) (← links)
• Blood flow and stem cells in vascular disease (Q38091966) (← links)
• Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury (Q38332355) (← links)
• Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease (Q38520485) (← links)
• High-Throughput RNAi Screening Identifies a Role for the Osteopontin Pathway in Proliferation and Migration of Human Aortic Smooth Muscle Cells (Q38878829) (← links)
• Blood level of CD45 platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease (Q39381245) (← links)
• Application of galangin, an active component of Alpinia officinarum Hance (Zingiberaceae), for use in drug-eluting stents (Q41418327) (← links)
• A Cytokine-Like Protein Dickkopf-Related Protein 3 Is Atheroprotective (Q42073870) (← links)
• Nitinol-Based Nanotubular Arrays with Controlled Diameters Upregulate Human Vascular Cell ECM Production (Q42355407) (← links)
• Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery (Q44814390) (← links)
• A link between stent radial forces and vascular wall remodeling: the discovery of an optimal stent radial force for minimal vessel restenosis (Q44955843) (← links)
• Alterations in wall shear stress predict sites of neointimal hyperplasia after stent implantation in rabbit iliac arteries. (Q46007737) (← links)
• Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation. (Q46030040) (← links)
• Estrogen enhances vasoconstrictive remodeling after injury in male rabbits. (Q46683244) (← links)
• Cost-effectiveness of the Taxus paclitaxel-eluting stent in the Swedish healthcare system (Q46921049) (← links)
• Use of heparin-coated stents in neurovascular interventional procedures: preliminary experience with 10 patients (Q48397516) (← links)
• Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis (Q50495566) (← links)
• Association between proliferative scars and in-stent restenosis (Q50855693) (← links)
• Assessment of coronary artery stents using 16-slice MDCT angiography: evaluation of a dedicated reconstruction kernel and a noise reduction filter (Q51540499) (← links)
• A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. (Q52938770) (← links)
• Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells (Q82207320) (← links)